Lupus Cost Regression Analysis

Project: Research

Project Details

Project Description

As requested by GSK, we have agreed to use our existing lupus cost data to prepare cost regression modelling report in line with GSK internal costing procedures.
StatusFinished
Effective start/end date17/12/1816/12/20

Funding

  • GlaxoSmithKline (GSK) Australia: AUD90,858.74